Study Evaluating Enbrel in Patients With Rheumatoid Arthritis
The purpose of this study is to investigate the incidence of adverse events for patients with rheumatoid arthritis treated with Enbrel under usual care settings. In addition, differences in injection site reactions based on whether health care professionals or patients administer Enbrel will be assessed and evaluated.
|Study Design:||Time Perspective: Prospective|
|Official Title:||Observational Study With Enbrel in Patients With Rheumatoid Arthritis|
Please refer to this study by its ClinicalTrials.gov identifier: NCT00245934
|Study Director:||Medical Monitor||Wyeth is now a wholly owned subsidiary of Pfizer|
|Principal Investigator:||Trial Manager||For Germany, MedinfoDEU@wyeth.com|